Skip to main content
. 2020 Jun 17;146(2):300–306. doi: 10.1016/j.jaci.2020.06.009

Table II.

Potential risk factors predisposing for severe COVID-19

Established/reported:
 Male sex
 Advanced age (>60 y)
 Arterial hypertension
 Diabetes mellitus
 Severe bronchial or pulmonary disease
 Clinically overt cardiac diseases
 Active advanced cancer (solid tumor)
 Active advanced hematologic neoplasm
 Hereditary or acquired immunodeficiency
 Cytotoxic chemotherapy inducing cytopenia
 Continuous immunosuppressive therapy
 Severe uncontrolled allergic asthma
Not established but discussed:
 Nicotine consumption
 No previous exposure to other coronaviruses
 Initial viral load
 Moderate or severe adipositas
 Treatment with NSAID
 Treatment with ACE inhibitors or ARB
 Vitamin D deficiency
 Vitamin C deficiency
 Copper and/or zinc deficiency
 Allergy—atopic disorders
 Chronic pulmonary disease due to air pollution and smog
 Bacterial superinfection in the lung
 Chronic bronchitis
 Pulmonary hypertension
 Blood group A, B, or AB

ACE, Angiotensin-converting enzyme; ARB, angiotensin II type 1 receptor blocker; NSAID, nonsteroidal anti-inflammatory drug.

Reported in peer-reviewed journal with solid data (any evidence level).

Some of these factors may be underestimated and may also play a role in other models of viral infections.